c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis. Academic Article uri icon

Overview

abstract

  • Fibrosis is a common pathological feature of chronic disease. Deletion of the NF-κB subunit c-Rel limits fibrosis in multiple organs, although the mechanistic nature of this protection is unresolved. Using cell-specific gene-targeting manipulations in mice undergoing liver damage, we elucidate a critical role for c-Rel in controlling metabolic changes required for inflammatory and fibrogenic activities of hepatocytes and macrophages and identify Pfkfb3 as the key downstream metabolic mediator of this response. Independent deletions of Rel in hepatocytes or macrophages suppressed liver fibrosis induced by carbon tetrachloride, while combined deletion had an additive anti-fibrogenic effect. In transforming growth factor-β1-induced hepatocytes, c-Rel regulates expression of a pro-fibrogenic secretome comprising inflammatory molecules and connective tissue growth factor, the latter promoting collagen secretion from HMs. Macrophages lacking c-Rel fail to polarize to M1 or M2 states, explaining reduced fibrosis in RelΔLysM mice. Pharmacological inhibition of c-Rel attenuated multi-organ fibrosis in both murine and human fibrosis. In conclusion, activation of c-Rel/Pfkfb3 in damaged tissue instigates a paracrine signalling network among epithelial, myeloid and mesenchymal cells to stimulate fibrogenesis. Targeting the c-Rel-Pfkfb3 axis has potential for therapeutic applications in fibrotic disease.

authors

publication date

  • November 9, 2020

Research

keywords

  • Epithelium
  • Liver Cirrhosis
  • Macrophages
  • Proto-Oncogene Proteins c-rel

Identity

PubMed Central ID

  • PMC7116435

Scopus Document Identifier

  • 85096015952

Digital Object Identifier (DOI)

  • 10.1016/S0002-9440(10)62291-2

PubMed ID

  • 33168981

Additional Document Info

volume

  • 2

issue

  • 11